U.S. Industrial REITs Stock News

NYSE:MTN
NYSE:MTNHospitality

Vail Resorts (MTN) Eyes Cost Savings And Guest Spend, Is The Stock Fully Priced?

Vail Resorts (MTN) has trailed the S&P 500 over the past six months, gaining 7.6% versus the index's 13.9% return. Investors are weighing weaker skier visit growth and its effect on revenue and reinvestment capacity. See our latest analysis for Vail Resorts. Over the past year, Vail Resorts’ share price return has been relatively muted, with a 90 day share price gain of 18.6% contrasting with a 1 year total shareholder return of just 1.25%. This suggests recent momentum has picked up after a...
NYSE:BXMT
NYSE:BXMTMortgage REITs

Blackstone Mortgage Trust (BXMT) Stock Looks Above Fair Value But Sales Look Weak

Blackstone Mortgage Trust stock has been under pressure in 2026, with the share price down 26.9% year to date, while the company still screens as expensive on Simply Wall St's valuation checks rather than as a clear bargain. Year to date the stock has declined 26.9%, which puts recent valuation questions front and centre for anyone already holding or looking at Blackstone Mortgage Trust. The recent decision to place about US$1b of office loans on a watch list may weigh on sentiment, while...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

How Rising Losses And Milestone Spending At GH Research (GHRS) Have Changed Its Investment Story

GH Research PLC has reported past earnings for the second quarter and six months ended June 30, 2026, with net losses of US$15.15 million and US$34.11 million respectively, and basic loss per share from continuing operations of US$0.23 and US$0.53. The widening losses compared with the prior year period place renewed attention on the company’s spending profile and progress toward its clinical and operational milestones. With these wider reported losses as a backdrop, we will now examine how...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

GLOBALFOUNDRIES (GFS) Is Up 6.8% After Real-Time AI Data Platform Deal With Redpanda Inc.

Earlier in August 2026, GlobalFoundries Inc. reported second-quarter 2026 results showing sales of US$1,786 million and net income of US$166 million, while also issuing third-quarter guidance, and separately announced a collaboration in which GlobalFoundries selected Redpanda Inc. to build a unified real-time data and AI platform across its global operations. This partnership is material because consolidating equipment, process, engineering, supply chain and manufacturing data into a single...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Can Columbia Banking System (COLB) Stay Below Fair Value For Long?

Columbia Banking System stock has almost doubled investors' money over the past three years, yet the current checks suggest a more nuanced picture, with the intrinsic value estimate pointing to upside while market multiples look roughly in line with peers. That mix raises the question of whether the recent share price is still conservative or already baking in much of the good news. Columbia Banking System has returned 99.3% over three years, which puts extra weight on whether the current...
NasdaqGS:CRAI
NasdaqGS:CRAIProfessional Services

What’s Behind CRA International (CRAI) Stock’s Latest Move?

CRA International (CRAI) is in focus after reporting second quarter results that exceeded analyst expectations, along with broad-based growth in key consulting practices that accounted for more than 95% of total revenue. See our latest analysis for CRA International. The latest results and refinancing news come after a mixed share price run for CRA International, with the stock down 18.11% on a year to date share price basis but still showing a 59.37% three year total shareholder return. This...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) After Mixed Earnings What Does The Valuation Narrative Say

Axsome Therapeutics earnings spark fresh look at the stock Axsome Therapeutics (AXSM) shares are back in focus after the company reported second quarter 2026 results on 10 August. Revenue for the period and first half increased, while net losses also widened. See our latest analysis for Axsome Therapeutics. Following the earnings release, Axsome Therapeutics shares have eased over the past month, with a 30 day share price return of 7.1% and a 7 day share price return of 3.3%. However, the...
NYSE:BAH
NYSE:BAHProfessional Services

What Does Booz Allen Hamilton (BAH) Gain From Its $1.2 Billion Notes Offering?

Booz Allen Hamilton Holding (NYSE: BAH) has completed a US$1.2b debt issuance through Senior Notes due 2030 and 2034, backed by a parent guarantee. The new Senior Notes add long dated funding to the company’s capital structure with staggered maturities in 2030 and 2034. The offering provides additional financial flexibility that management can deploy across future growth initiatives and general corporate purposes. For investors who see Booz Allen Hamilton’s latest financing move as part of...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs (CLF) Stock May Be 41% Undervalued On Sales And Cash Flow

Cleveland-Cliffs stock has delivered a steep loss of about 48.1% over the past five years, yet current valuation checks and the intrinsic value estimate using a Discounted Cash Flow (DCF) approach both point to shares trading at a discount to what the business may be worth. That disconnect between a weak long term share price record and an apparently cheap valuation is what investors now need to weigh. The roughly 48.1% decline over five years means long term holders have seen significant...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics (GPCR) As August Updates Reframe The Case For Its Valuation

Structure Therapeutics (GPCR) has drawn investor attention after a packed August 6 update that combined second quarter earnings, fresh timelines for aleniglipron clinical data, and the appointment of experienced commercial leader John Berrios. See our latest analysis for Structure Therapeutics. At a recent share price of US$54.51, Structure Therapeutics has seen strong momentum in recent months, with a 30 day share price return of 12.44% and a 90 day share price return of 51.92%. However, the...
NYSE:MWA
NYSE:MWAMachinery

Mueller Water Products (MWA) Acquisition Plans Put Fair Value Back In Focus

Mueller Water Products (MWA) is back in focus after confirming active plans to pursue acquisitions, supported by a sizable cash position, extended debt maturities, and an ongoing share repurchase program that has reduced the share count. See our latest analysis for Mueller Water Products. The recent announcement on acquisitions and completed buybacks comes after a steady year, with Mueller Water Products showing a 5.18% year to date share price return and a 3 year total shareholder return of...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock (BLK) Stock May Be 1% Overvalued As AI Financing Expands

BlackRock stock is coming off a strong three year run, with the share price now around US$1,147, yet the valuation checks show limited signs of a clear bargain and an intrinsic value estimate that sits close to where the market is already pricing it. BlackRock has returned about 83% over the past three years, which puts more pressure on today’s buyers to justify the current price with future cash flows. Recent involvement in large scale AI infrastructure and data center financing can support...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope (NTSK) Unveils One DataSec Command Center For AI And Cloud Data Protection

Netskope (NasdaqGS:NTSK) has introduced the Netskope One DataSec Command Center, a unified control plane for data security across AI, cloud, network, and endpoints. The new platform focuses on sensitive data monitoring, risk discovery, and automated remediation across heterogeneous environments. Security teams can correlate signals from multiple data security modules to streamline incident response and support AI driven operations. The launch coincides with Netskope’s presence at a major...
NYSE:HLT
NYSE:HLTHospitality

Hilton Worldwide Holdings (HLT) Draws Valuation Focus, Is The Stock Fully Priced?

Hilton Worldwide Holdings (HLT) has drawn investor attention after its recent share move, with the stock last closing at US$326.12. That price now sits alongside a market value of about US$73.6b. See our latest analysis for Hilton Worldwide Holdings. The recent 7 day share price return of 4.86% for Hilton Worldwide Holdings sits within a broader pattern, with the year to date share price return of 11.31% and a 1 year total shareholder return of 21.41% pointing to steady, sustained momentum...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Bitdeer Technologies Group (BTDR) Is Up 8.0% After $4.7 Billion Tydal AI Colocation Deal - Has The Bull Case Changed?

Bitdeer Technologies Group recently secured a 16-year colocation lease and services agreement via its Tydal Data Center AS subsidiary with Volta Tydal AS for 121 IT megawatts at its Tydal, Norway campus, backed by credit support from affiliates of J.P. Morgan and another global financial institution and with remaining capex of about US$500 million. The deal is expected to deliver about US$4.70 billion in contracted revenue over the initial term, potentially rising to about US$8.00 billion...
NYSE:GM
NYSE:GMAuto

What Does General Motors (GM) Restarting Its Ohio Battery Plant Signal?

General Motors (NYSE: GM) joint venture Ultium Cells is restarting production at its Warren, Ohio battery plant after a seven month shutdown tied to a reset of US BEV plans and policy responses. The plant pause followed weaker US battery electric vehicle demand and changes to purchase incentives that affected GM’s near term EV rollout plans. Ultium Cells’ restart is expected to reshape GM’s EV battery supply, cost profile, and positioning in the US electric vehicle market. For investors...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Is Immunocore Holdings (IMCR) Undervalued After Stronger Revenue And Profitability Results?

Immunocore Holdings (IMCR) reported its second quarter and six month results on August 6, 2026, with higher revenue and a move from a net loss to net income over the half year period. See our latest analysis for Immunocore Holdings. At a share price of US$34.21, Immunocore Holdings shows a 90 day share price return of 18.25%, while the 1 year total shareholder return of 5.88% contrasts with a 3 year total shareholder return that is down 42.85%. This suggests that momentum has been rebuilding...
NYSE:VAC
NYSE:VACHospitality

Marriott Vacations Worldwide (VAC) Picks Vlad Anokhin To Lead Transformation

Marriott Vacations Worldwide (NYSE:VAC) appointed Vlad Anokhin as Chief Strategy & Transformation Officer, with responsibilities across data analytics, artificial intelligence and product development. Anokhin will lead company wide transformation efforts, with a focus on digital capabilities and new product initiatives. The leadership change indicates a potential shift in how Marriott Vacations Worldwide approaches technology driven decision making and long term planning. For investors who...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron (ITRI) Gets A Fresh Look As Its Undervalued Story Gains Ground

Itron (ITRI) has drawn fresh attention after Zacks upgraded the stock to Rank #2, citing higher earnings estimates that place the company among the stronger estimate revision stories on its coverage list. See our latest analysis for Itron. Itron’s recent Zacks Rank upgrade comes after a strong 30-day share price return of 17% and a 90-day share price return of 28.95%, even though the 1-year total shareholder return is down 21.02%. This keeps longer term sentiment more mixed. If you are...
NYSE:MANU
NYSE:MANUEntertainment

Manchester United (MANU) Stock Looks Rich Following Its 48% Run

Manchester United stock has rallied strongly in 2026, yet the valuation signals are pulling in different directions. An intrinsic value estimate from a Discounted Cash Flow (DCF) model points to a discount, while market based multiples suggest the shares are priced more richly. Year to date, Manchester United is up 47.6%, which puts extra focus on whether the current share price still leaves enough potential reward for the risk involved. Future cash generation from media rights and...
NasdaqGS:PPC
NasdaqGS:PPCFood

Pilgrim's Pride Stock And 2 Agriculture Producers Tied To Brazil Tariffs

Trade friction between the U.S. and Brazil is suddenly front and center, with fresh tariffs on Brazilian exports reshaping the balance for global crop suppliers. When a major competitor faces new hurdles, companies with similar products can sometimes see new openings or fresh risks. This article walks through three U.S.-listed agriculture and food producers that are closely tied to this story and explains how the latest headlines may affect their stocks. The three stocks covered below are...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Commerce Bancshares (CBSH) Trades At A P/E Premium, Is The Discount Case More Convincing?

Commerce Bancshares (CBSH) is drawing attention after recent share price moves, with the stock closing at $60.27. Investors are weighing this valuation against its recent total returns and current profitability profile. See our latest analysis for Commerce Bancshares. Commerce Bancshares' 0.45% 1 day share price return builds on a 16.4% 90 day share price return, while the 3 year total shareholder return of 48.48% points to momentum that has developed over a longer period. If you are...
NYSE:AUB
NYSE:AUBBanks

Atlantic Union Bankshares (AUB) Stock Looks Reasonable On Earnings While Cash Flow Stays Strong

Atlantic Union Bankshares has delivered a strong 58.2% return over the past three years, yet its current checks suggest the stock now sits closer to fair value on traditional multiples while an Excess Returns estimate points to a discount to intrinsic value. For investors, the question is whether that combination of solid past returns and a mixed valuation read still leaves enough room for attractive upside. Atlantic Union Bankshares has returned 58.2% over three years, which puts recent...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Is Buybacks And Higher 2026 Guidance Altering The Investment Case For Viatris (VTRS)?

In early August 2026, Viatris reported second-quarter results showing higher sales and revenue than a year earlier, while also completing a share repurchase program of 103,547,908 shares for about US$1.15 billion and affirming a quarterly dividend of US$0.12 per share. The company paired this capital return with a modest increase to its 2026 revenue guidance midpoint to US$14.75 billion, suggesting management’s confidence in its operating direction despite reporting a second-quarter net...